As of 2024-12-14, the Relative Valuation of Antares Pharma Inc (ATRS) is 9.10 USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.59 USD, the upside of Antares Pharma Inc based on Relative Valuation is 62.8%.
The range of the Relative Valuation is 7.22 - 9.90 USD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 21.7x - 29.7x | 27.3x |
| Fair Price | 7.22 - 9.90 | 9.10 |
| Upside | 29.2% - 77.1% | 62.8% |
| Date | P/E |